Detalles de la búsqueda
1.
Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study.
Clin Gastroenterol Hepatol
; 22(1): 154-163.e3, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442318
2.
Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility.
Clin Gastroenterol Hepatol
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38788915
3.
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial.
Gastroenterology
; 163(5): 1294-1305.e3, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940251
4.
Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational study.
BMC Gastroenterol
; 23(1): 417, 2023 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030966
5.
A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR Index.
Clin Gastroenterol Hepatol
; 20(5): e1040-e1049, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34216820
6.
Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study.
Scand J Gastroenterol
; 57(4): 439-445, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34968158
7.
Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers.
Clin Gastroenterol Hepatol
; 19(6): 1218-1225.e4, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445951
8.
Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 17(5): 838-846.e2, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29935327
9.
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview.
BMC Med
; 17(1): 89, 2019 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31064370
10.
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab.
Clin Gastroenterol Hepatol
; 16(8): 1276-1283.e1, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29203225
11.
An Unfortunate Consequence of Duodenogastric Reflux.
Gastroenterology
; 158(4): 836-837, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31404534
12.
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation.
Gut
; 68(1): 178-179, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29331941
13.
Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!
Gastroenterology
; 154(4): 1196-1198, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29391131
14.
Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 16(11): 1839, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30343866
15.
Tofacitinib Is the Right OCTAVE for Ulcerative Colitis.
Gastroenterology
; 153(3): 862-864, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28757262
16.
Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO Study.
J Crohns Colitis
; 17(7): 1046-1054, 2023 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708189
17.
Results of the Eighth Scientific Workshop of ECCO: Prevention and Treatment of Postoperative Recurrence in Patients With Crohn's Disease Undergoing an Ileocolonic Resection With Ileocolonic Anastomosis.
J Crohns Colitis
; 17(11): 1707-1722, 2023 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37070324
18.
Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic Trial.
J Crohns Colitis
; 16(2): 199-206, 2022 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297099
19.
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
Inflamm Bowel Dis
; 28(2): 208-217, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33783494
20.
Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USA.
Expert Opin Biol Ther
; 21(1): 111-119, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33107355